Drug Shortage Report for CEFAZOLIN FOR INJECTION, USP

Last updated on 2020-01-16 History
Report ID 76590
Drug Identification Number 02401029
Brand name CEFAZOLIN FOR INJECTION, USP
Common or Proper name Cefazolin for Injection, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CEFAZOLIN
Strength(s) 100G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 100g SmartPak
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-11-01
Actual start date
Estimated end date 2019-12-16
Actual end date 2020-01-13
Shortage status Resolved
Updated date 2020-01-16
Company comments Product Available 25% Allocation effective January 13th, 2020
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-01-16 French Compare
v8 2020-01-16 English Compare
v7 2019-11-02 English Compare
v6 2019-10-28 French Compare
v5 2019-10-28 English Compare
v4 2019-02-22 English Compare
v3 2019-02-21 French Compare
v2 2019-02-21 English Compare
v1 2019-02-21 English Compare